ÂÜÀòÂÒÂ×

Catherine W. Parham is the Chief medical officer and executive vice president of medical and clinical affairs at Sirtex. As the company’s principal medical expert, she develops the strategic vision for the clinical trial portfolio.

Before joining Sirtex in 2022, Dr. Parham served as vice president and head of global medical affairs for Astellas Gene Therapies. Prior to that, she was vice president, global program lead, and R&D, of Takeda Pharmaceutical’s Plasma-Derived Therapies business unit, and held leadership positions at Shire, Pfizer, GE Healthcare, Johnson & Johnson, and Millennium Pharmaceuticals. Additionally, Dr. Parham has served as an instructor of anesthesia and critical care at both Harvard Medical School/Beth Israel Deaconess Medical Center and Boston University School of Medicine.